EA202092648A1 - SOLID FORMS OF FGFR INHIBITOR AND METHODS FOR THEIR PREPARATION - Google Patents

SOLID FORMS OF FGFR INHIBITOR AND METHODS FOR THEIR PREPARATION

Info

Publication number
EA202092648A1
EA202092648A1 EA202092648A EA202092648A EA202092648A1 EA 202092648 A1 EA202092648 A1 EA 202092648A1 EA 202092648 A EA202092648 A EA 202092648A EA 202092648 A EA202092648 A EA 202092648A EA 202092648 A1 EA202092648 A1 EA 202092648A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
solid forms
methods
fgfr inhibitor
fgfr
Prior art date
Application number
EA202092648A
Other languages
Russian (ru)
Inventor
Тимоти С. Берн
Филип С. Лю
Уилльям Фритце
Чжунцзян Цзя
Мин Тао
Дэнцзинь Ван
Цзячэн Чжоу
Цюнь Ли
Original Assignee
Инсайт Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Корпорейшн filed Critical Инсайт Корпорейшн
Priority claimed from PCT/US2019/030633 external-priority patent/WO2019213544A2/en
Publication of EA202092648A1 publication Critical patent/EA202092648A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к 3-(2,6-дифтор-3,5-диметоксифенил)-1-этил-8-(морфолин-4-илметил)-1,3,4,7-тетрагидро-2H-пирроло[3',2':5,6]пиридо[4,3-d]пиримидин-2-ону, его твердым формам и полиморфам, способам их получения и промежуточным соединениям при их получении, которые применимы при лечении FGFR-ассоциированных или опосредованных заболеваний, таких как рак.The present invention relates to 3- (2,6-difluoro-3,5-dimethoxyphenyl) -1-ethyl-8- (morpholin-4-ylmethyl) -1,3,4,7-tetrahydro-2H-pyrrolo [3 ' , 2 ': 5,6] pyrido [4,3-d] pyrimidin-2-one, its solid forms and polymorphs, processes for their preparation and intermediates upon their preparation, which are useful in the treatment of FGFR-associated or mediated diseases such like cancer.

EA202092648A 2019-03-08 2019-05-03 SOLID FORMS OF FGFR INHIBITOR AND METHODS FOR THEIR PREPARATION EA202092648A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962815539P 2019-03-08 2019-03-08
PCT/US2019/030633 WO2019213544A2 (en) 2018-05-04 2019-05-03 Solid forms of an fgfr inhibitor and processes for preparing the same

Publications (1)

Publication Number Publication Date
EA202092648A1 true EA202092648A1 (en) 2021-03-24

Family

ID=75262214

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092648A EA202092648A1 (en) 2019-03-08 2019-05-03 SOLID FORMS OF FGFR INHIBITOR AND METHODS FOR THEIR PREPARATION

Country Status (1)

Country Link
EA (1) EA202092648A1 (en)

Similar Documents

Publication Publication Date Title
MX2023002034A (en) Solid forms of an fgfr inhibitor and processes for preparing the same.
EA202092649A1 (en) FGFR INHIBITOR SALTS
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
EA202092410A1 (en) CONJUGATES OF CAMPTOTHETCIN WITH PEPTIDE
EA202092896A1 (en) HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
PH12020552148A1 (en) Purinone compounds and their use in treating cancer
MX2021008145A (en) Diaryl macrocycle polymorph.
PH12018500958A1 (en) Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer
EA201891983A8 (en) COMBINED THERAPY BY ANTIBODIES TO CD73
EA201992794A1 (en) CRYSTAL FORM OF THE FGFR INHIBITOR AND METHODS FOR PRODUCING THEM
EA201692095A1 (en) IMIDAZO [4,5-C] QUINOLIN-2-NEW COMPOUNDS AND THEIR APPLICATION IN CANCER TREATMENT
MX2018004954A (en) Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer.
WO2014081906A3 (en) Substituted reverse pyrimidine bmi-1 inhibitors
EA201690502A1 (en) SUBSTITUTED PYRIMIDINE INHIBITORS BMI-1
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
EA201070929A1 (en) FURO-THYENO [3,2-c] Pyridine
EA201991729A1 (en) ANTIBODIES TO TGF-BETA AND THEIR APPLICATION
EA202191764A1 (en) SUBSTITUTED OXOPYRIDINE DERIVATIVES
MA34968B1 (en) ASYMMETRIC UREA AND MEDICAL USES THEREOF
EA201291346A1 (en) POLYMORPHY OSI-906
EA202092125A1 (en) ANTIBODIES AGAINST FOLATE 1 RECEPTOR AND THEIR APPLICATION
MX2022012471A (en) Combinations of menin inhibitors and cyp3a4 inhibitors and methods of use thereof.
EA201891611A1 (en) DERIVATIVES 3 - ((HETERO-) Aryl) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN
EA201992343A1 (en) SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS NADPH-OXIDASE INHIBITORS
EA202092648A1 (en) SOLID FORMS OF FGFR INHIBITOR AND METHODS FOR THEIR PREPARATION